UD 039
Alternative Names: UD-039Latest Information Update: 21 Oct 2024
At a glance
- Originator Ube Industries
- Class
- Mechanism of Action Lysophosphatidic acid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neuropathic pain